Skip Navigation


Japanese Journal of Clinical Oncology Advance Access originally published online on January 31, 2008
Japanese Journal of Clinical Oncology 2008 38(1):64-70; doi:10.1093/jjco/hym147
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow All Versions of this Article:
38/1/64    most recent
hym147v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Request Permissions
Google Scholar
Right arrow Articles by Kim, M. K.
Right arrow Articles by Lee, K. H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kim, M. K.
Right arrow Articles by Lee, K. H.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?


© The Author (2008). Published by Oxford University Press. All rights reserved

Palliative Chemotherapy Preferences and Factors that Influence Patient Choice in Incurable Advanced Cancer

Min Kyoung Kim1,, Jae-Lyun Lee2, Myung Soo Hyun1, Young Rok Do3, Hong Suk Song3, Jong Gwang Kim4, Sung Hwa Bae5, Hun Mo Ryoo5, Keon Uk Park6 and Kyung Hee Lee1

1 Department of Internal Medicine, Yeungnam University College of Medicine, Gyeongju, South Korea
2 Department of Internal Medicine, Asan Medical Center, Gyeongju, South Korea
3 Department of Internal Medicine, Keimyung University College of Medicine, Gyeongju, South Korea
4 Department of Internal Medicine, Kyoungpook National University Hospital, Gyeongju, South Korea
5 Department of Internal Medicine, Daegu Catholic University College of Medicine, Daegu, Gyeongju, South Korea
6 Department of Internal Medicine, Dongguk University College of Medicine, Gyeongju, South Korea

For reprints and all correspondence: Kyung Hee Lee, Division of Oncology, Department of Internal Medicine, Yeungnam University College of Medicine, 317-1 Daemyung dong, Namgu, Daegu 705-717, South Korea. E-mail: lkhee{at}medical.yu.ac.kr

Received June 21, 2007; accepted October 8, 2007

Objective: To determine the extent of informed decision-making and treatment preference of Korean patients receiving palliative chemotherapy.

Methods: We assessed 138 patients (median age: 58 years; 73% male) with advanced cancer who had received at least one cycle of chemotherapy. General demographic information, the extent of information received, patient preferences for palliative chemotherapy and randomized trials were determined using structured patient interviews. We investigated the survival threshold for justifying toxicity, the factors influencing individual preference for chemotherapy and the attitude of patients towards randomized trials.

Results: Before chemotherapy, 72.1% of patients were given information about adverse events of treatment, but only 39.5% were told of alternative treatments. There was significant inter-individual variability in willingness to accept chemotherapy, as well as a wide range of thresholds. Patients reporting higher quality of life were more likely to judge treatment as acceptable. When given the choice for randomization for conventional chemotherapy, investigational agents or supportive care, patients usually refused enrollment into randomized trials.

Conclusion: Self-assessed quality of life was a significant predictor of stronger preference for chemotherapy. In the palliative setting, good doctor–patient communications and consideration of patients' preferences are necessary for making decisions about proper treatment.

Key Words: palliative care • quality of life • clinical trial


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?




Disclaimer:
Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.